Home
/
CorMedix Inc.
/
Financials
/
Quarterly
CorMedix Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that CorMedix Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$104.28M
Nov 12, 2025
Q2
2025
Jun 30, 2025
$39.74M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$39.08M
May 6, 2025
Q3
2025
Sep 30, 2024
$11.46M
Nov 12, 2025
Q2
2025
Jun 30, 2024
$806.1K
Aug 7, 2025
Q3
2023
Sep 30, 2022
$6.8K
Nov 14, 2023
Q2
2023
Jun 30, 2022
$21.3K
Aug 8, 2023
Q1
2023
Mar 31, 2022
$7.6K
May 15, 2023
Q3
2022
Sep 30, 2021
$38.1K
Nov 10, 2022
Q2
2022
Jun 30, 2021
$8.2K
Aug 11, 2022
Q1
2022
Mar 31, 2021
$88.3K
May 12, 2022
Q3
2021
Sep 30, 2020
$93.0K
Nov 9, 2021
Q2
2021
Jun 30, 2020
$16.4K
Aug 12, 2021
Q1
2021
Mar 31, 2020
$74.1K
May 13, 2021
Q3
2020
Sep 30, 2019
$59.5K
Nov 5, 2020
Q2
2020
Jun 30, 2019
$35.3K
Aug 10, 2020
Q1
2020
Mar 31, 2019
$163.7K
May 11, 2020
Q3
2019
Sep 30, 2018
$372.5K
Nov 14, 2019
Q2
2019
Jun 30, 2018
$7.6K
Aug 14, 2019
Q1
2019
Mar 31, 2018
$23.2K
May 13, 2019
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$108.56M
Nov 12, 2025
Q2
2025
Jun 30, 2025
$19.83M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$20.64M
May 6, 2025
Q3
2025
Sep 30, 2024
($2.78M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($14.15M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($14.47M)
May 6, 2025
Q3
2024
Sep 30, 2023
($9.74M)
Oct 30, 2024
Q2
2024
Jun 30, 2023
($11.27M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($10.57M)
May 9, 2024
Q3
2023
Sep 30, 2022
($6.85M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($7.60M)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($7.03M)
May 15, 2023
Q3
2022
Sep 30, 2021
($8.57M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($4.63M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($7.22M)
May 12, 2022
Q3
2021
Sep 30, 2020
($6.60M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
($3.78M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($5.56M)
May 13, 2021
Q3
2020
Sep 30, 2019
($5.26M)
Nov 5, 2020
Q2
2020
Jun 30, 2019
($696.2K)
Aug 10, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$51.35M
Nov 12, 2025
Q2
2025
Jun 30, 2025
$19.54M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$20.13M
May 6, 2025
Q3
2025
Sep 30, 2024
($3.29M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($15.30M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($16.70M)
May 6, 2025
Q3
2024
Sep 30, 2023
($10.47M)
Oct 30, 2024
Q2
2024
Jun 30, 2023
($11.80M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($11.02M)
May 9, 2024
Q3
2023
Sep 30, 2022
($6.96M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($8.24M)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($7.03M)
May 15, 2023
Q3
2022
Sep 30, 2021
($8.56M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($5.88M)
Aug 11, 2022
Q1
2022
Mar 31, 2021
($7.21M)
May 12, 2022
Q3
2021
Sep 30, 2020
($6.60M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
($8.92M)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($5.61M)
May 13, 2021
Q3
2020
Sep 30, 2019
($5.17M)
Nov 5, 2020
Q2
2020
Jun 30, 2019
($5.54M)
Aug 10, 2020